Oct 28 (Kyodo) - U.S. pharmaceutical giant Pfizer Inc. is in talks with Japan to apply for approval to administer its COVID-19 vaccine to children aged 5 to 11, sources close to the matter said Wednesday.
The revelation came a day after a U.S. Food and Drug Administration panel of independent experts voted in favor of issuing emergency use authorization for the vaccine to be administered to children in that age group.
Source: ANNnewsCH